• Swindon & Wiltshire M&A, deals
• Wednesday November 6 2024
• Author Name: Peter Davison

Bristol-based fertility centre acquired by European health provider

Independent fertility clinic Bristol Centre for Reproductive Medicine has been acquired by a private equity-backed European provider in reproductive medicine and genetics.

FutureLife Group, which has more than 40 clinics across eight countries, has acquired BCRM in a move to expand its UK presence.

BCRM operates from a state-of-the-art facility in Bristol’s Aztec West, offering IVF, ICSI, IUI, egg freezing, donor sperm and other treatments.

The centre has been a cornerstone of fertility services in the Bristol region for more than 40 years.

Originally established as a joint research project between the University of Bristol and Southmead Hospital, BCRM transitioned to an independent clinic in 2018.

BCRM also has satellite clinics in Bristol Spire, Bath, Cardiff, Swindon and Jersey.

Dr Valentine Akande, medical director and lead clinician at BCRM said: “Joining FL is a milestone for BCRM, giving us access to strategic resources and expertise within a leading international network.

“This partnership will help us expand our services and continue delivering the high-quality, patient-centred care that has been our foundation for over 40 years.

“We’re incredibly thankful to the entire Grant Thornton team for their invaluable partnership throughout this transaction.

“Their persistence and dedication were key to completing the deal within a challenging timeline and securing an outstanding outcome for our business.”

BCRM was advised by the corporate finance team at Grant Thornton, led by director Nick Jones.

“The BCRM brand reputation is an extremely strong one, with an unwavering commitment to medical excellence, innovation and its compassionate approach,” said Nick

“This transaction in the fertility space represents an exceptional outcome for all parties and a high-quality addition to the FL brand.”

Law firm Gardner Leader, led by corporate partner James Thorpe, supported by Gail Vallis, advised BCRM’s shareholders.